Table 3.
Health care utilization and work-related impairment.
| Effective n | FGID patients in total∗ (n = 271) [20] | Patients with 1 FGID diagnosis (n = 141) | Patients with >1 FGID diagnoses (n = 130)∗∗ | p value | |
|---|---|---|---|---|---|
| Appointments in the FGID clinic (1 year)2 | 268 | 2.00 [2.00] | 2.00 [2.00] | 2.00 [2.00] | 0.958c |
| n = 1, n (%) | 268 | 122 (45.52) | 62 (44.93) | 60 (46.15) | 0.840c |
| n = 2, n (%) | 268 | 76 (28.36) | 40 (28.99) | 36 (27.69) | 0.814c |
| n = 3, n (%) | 268 | 39 (14.55) | 22 (15.94) | 17 (13.07) | 0.506c |
| n ≥ 4, n (%) | 268 | 31 (11.57) | 14 (10.14) | 17 (13.07) | 0.453c |
| Appointment in the psychosomatic outpatient clinic of Heidelberg University, n (%) | 271 | 82 (30.26) | 40 (28.37) | 42 (32.31) | 0.481b |
| Medical appointments in the last 4 weeks2 | 259 | 2.00 [1.00] | 1.00 [1.00] | 2.00 [1.80] | 0.496c |
| n = 1, n (%) | 71 (27.41) | 38 (29.00) | 33 (25.78) | 0.561b | |
| n = 2, n (%) | 70 (27.03) | 32 (24.43) | 38 (29.69) | 0.341b | |
| n ≥ 3, n (%) | 64 (24.71) | 32 (24.43) | 32 (25.00) | 0.915b | |
| Psychotherapeutic treatment, n (%) | 262 | 139 (53.05) | 76 (55.47) | 63 (50.40) | 0.411b |
| Currently, n (%) | 70 (26.72) | 33 (24.09) | 37 (29.60) | 0.314b | |
| Previously, n (%) | 69 (26.34) | 43 (31.39) | 26 (20.80) | 0.052b | |
| Current medication for anxiety, depression, or stress, n (%) | 259 | 78 (30.12) | 40 (29.85) | 38 (30.40) | 0.923b |
| Previous inpatient stay, n (%) (lifetime) | 268 | 43 (16.04) | 21 (15.22) | 22 (16.92) | 0.704b |
| Psych. acute care hospital, n (%) | 27 (10.07) | 13 (9.42) | 14 (10.77) | 0.714b | |
| Psych. rehabilitation hospital, n (%) | 9 (3.36) | 5 (3.62) | 4 (3.08) | 1.000b | |
| Work-related impairment due to GI symptoms in the last year (IBS-SSS) | |||||
| Weeks absent from work (absenteeism)2 | 155 | 2.00 [6.00] | 1.00 [3.00] | 3.00 [10.00] | 0.002 c |
| Weeks at work suffering (presenteeism)2 | 83 | 25.00 [48.00] | 12.00 [31.00] | 38.00 [44.00] | 0.003 c |
1Mean (standard deviation). 2Median [interquartile range]. at-test. bχ2 test. cMann–Whitney U test. ∗Most of the data of the column with FGID patients in total were shown similarly in Berens et al. [20]. ∗∗All patients with >1 FGID diagnoses had two FGIDs.